{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:47:53Z","timestamp":1758268073310,"version":"3.44.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Hepatocellular carcinoma (HCC) is one of the most prevalent and inflammation-associated cancers. The potential prognostic value of calcyclin-binding protein (CACYBP) in HCC remains unclear. We aimed to perform meta-analysis to clarify the association of CACYBP expression with prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We searched various databases to collect all eligible studies. The meta-analysis was performed using Review manager V5.4.1. Gene expression profiling interactive analysis 2 (limma) and differential expression sequencing 2 on R 4.3.3 were used to look for differentially expressed genes. Gene-set enrichment analysis using 4 Gene Ontology databases (molecular function; biological process; cellular component; pathways) was performed using TCGAbiolinks on R. Survival analysis on The Cancer Genome Atlas-HCC was done using gene expression profiling interactive analysis 2.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Four studies were retrieved for meta-analysis. Overall survival (OS) (hazard ratio\u2005=\u20051.08; 95% confidence interval: 1.05\u20131.10), indicated that high CACYBP expression is associated with worse OS. The Cancer Genome Atlas validation consistently indicated that high CACYBP expression correlates with OS (hazard ratio: 1.24, <jats:italic toggle=\"yes\">P<\/jats:italic>-value: .04), indicating a worse prognosis. RNA sequencing analysis identified 2910 differentially expressed genes between high and low CACYBP expression groups. Gene-set enrichment analysis showed that upregulated genes in high CACYBP expressers relate to mitosis, nuclear division, cell cycle, microtubule cytoskeleton, ion channel activity, eIF2 signaling, and DNA damage responses. Conversely, downregulated genes were related to oxidation\u2013reduction, steroid metabolic process, response to hormone stimulus, ethanol\/acetone degradation, and immune\/inflammatory responses like liver X receptor\/retinoid X receptor regulation and complement system.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our results suggested that CACYBP expression in HCC is associated with enhanced cell proliferation and cell cycle progression, as well as altered metabolic and immune responses, which contribute to the poorer clinical and survival outcomes of patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000043694","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T23:01:14Z","timestamp":1754089274000},"page":"e43694","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["CACYBP expression predicts prognosis in hepatocellular carcinoma: A meta-analysis and bioinformatics validation"],"prefix":"10.1097","volume":"104","author":[{"given":"Ramez M.","family":"Odat","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jehad A.","family":"Yasin","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayham Mohammad","family":"Hussein","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Al-Balqa\u2019 Applied University, Salt, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fares A.","family":"Qtaishat","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Amer A.","family":"Tamimi","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hritvik","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakhr","family":"Alshwayyat","sequence":"additional","affiliation":[{"name":"Kern Medical (UCLA David Geffen School of Medicine Affiliate), Bakersfield, CA"},{"name":"Applied Science Research Center, Applied Science Private University, Amman, Jordan"},{"name":"King Hussein Cancer Center, Amman, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2970-7379","authenticated-orcid":false,"given":"Hamdah","family":"Hanifa","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Kalamoon, Al-Nabk, Syria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dang","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Corrigan Minehan Heart Center, Harvard Medical School, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250918","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250918","first-page":"443","article-title":"Cancer statistics for adolescents and young adults, 2020.","volume":"70","author":"Miller","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R3-20250918","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00408-021-00486-y","article-title":"Update 2021: management of small cell lung cancer.","volume":"199","author":"Tariq","year":"2021","journal-title":"Lung"},{"key":"R4-20250918","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.7150\/thno.36838","article-title":"CACYBP enhances cytoplasmic retention of P27(Kip1) to promote hepatocellular carcinoma progression in the absence of RNF41 mediated degradation.","volume":"9","author":"Lian","year":"2019","journal-title":"Theranostics"},{"issue":"1 Pt A","key":"R5-20250918","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbagen.2015.10.012","article-title":"CacyBP\/SIP \u2013 structure and variety of functions.","volume":"1860","author":"Topolska-Wo\u015b","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"R6-20250918","doi-asserted-by":"crossref","first-page":"e0169959","DOI":"10.1371\/journal.pone.0169959","article-title":"CacyBP\/SIP promotes the proliferation of colon cancer cells.","volume":"12","author":"Zhai","year":"2017","journal-title":"PLoS One"},{"key":"R7-20250918","first-page":"924","article-title":"CacyBP promotes the proliferation and invasion of non-small cell lung cancer.","volume":"43","author":"Xu","year":"2021","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"R8-20250918","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma.","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"R9-20250918","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","article-title":"Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma.","volume":"150","author":"Bruix","year":"2016","journal-title":"Gastroenterology"},{"key":"R10-20250918","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1369\/jhc.2008.950519","article-title":"Expression of calcyclin-binding protein\/Siah-1 interacting protein in normal and malignant human tissues: an immunohistochemical survey.","volume":"56","author":"Zhai","year":"2008","journal-title":"J Histochem Cytochem"},{"key":"R11-20250918","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1158\/1541-7786.MCR-06-0426","article-title":"Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer.","volume":"5","author":"Ning","year":"2007","journal-title":"Mol Cancer Res"},{"key":"R12-20250918","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1159\/000151774","article-title":"Expression and clinical significance of CacyBP\/SIP in pancreatic cancer.","volume":"8","author":"Chen","year":"2008","journal-title":"Pancreatology"},{"key":"R13-20250918","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1096\/fj.12-212282","article-title":"Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of \u03b2-catenin.","volume":"26","author":"Rines","year":"2012","journal-title":"FASEB J"},{"key":"R14-20250918","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s00268-010-0690-2","article-title":"CacyBP\/SIP expression is involved in the clinical progression of breast cancer.","volume":"34","author":"Wang","year":"2010","journal-title":"World J Surg"},{"key":"R15-20250918","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/iub.1263","article-title":"CacyBP\/SIP protein is important for the proliferation of human glioma cells.","volume":"66","author":"Shi","year":"2014","journal-title":"IUBMB Life"},{"key":"R16-20250918","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.bbrc.2007.03.080","article-title":"Overexpressed CacyBP\/SIP leads to the suppression of growth in renal cell carcinoma.","volume":"356","author":"Sun","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"R17-20250918","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1054\/bjoc.2000.1580","article-title":"Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma.","volume":"84","author":"Ito","year":"2001","journal-title":"Br J Cancer"},{"key":"R18-20250918","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R19-20250918","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors.","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"R20-20250918","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"R21-20250918","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells.","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"R22-20250918","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells.","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res"},{"key":"R23-20250918","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol"},{"key":"R24-20250918","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"R25-20250918","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data.","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"R26-20250918","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.12688\/f1000research.8923.1","article-title":"TCGA Workflow: analyze cancer genomics and epigenomics data using bioconductor packages.","volume":"5","author":"Silva","year":"2016","journal-title":"F1000Research"},{"key":"R27-20250918","doi-asserted-by":"crossref","first-page":"e1006701","DOI":"10.1371\/journal.pcbi.1006701","article-title":"New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx.","volume":"15","author":"Mounir","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"R28-20250918","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets.","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"R29-20250918","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.18632\/aging.102926","article-title":"Development of an immune-related prognostic index associated with hepatocellular carcinoma.","volume":"12","author":"Hu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"R30-20250918","doi-asserted-by":"crossref","first-page":"8291036","DOI":"10.1155\/2020\/8291036","article-title":"A novel signature based on mTORC1 pathway in hepatocellular carcinoma.","volume":"2020","author":"Mo","year":"2020","journal-title":"J Oncol"},{"key":"R31-20250918","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12935-021-01792-4","article-title":"Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.","volume":"21","author":"Peng","year":"2021","journal-title":"Cancer Cell Int"},{"key":"R32-20250918","doi-asserted-by":"crossref","first-page":"1166052","DOI":"10.3389\/fimmu.2023.1166052","article-title":"Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC.","volume":"14","author":"Shi","year":"2023","journal-title":"Front Immunol"},{"issue":"Suppl 0","key":"R33-20250918","first-page":"1105","article-title":"Epidemiology of hepatocellular carcinoma: consider the population.","volume":"47","author":"Mittal","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"R35-20250918","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/cells9061370","article-title":"Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment.","volume":"9","author":"Pi\u00f1ero","year":"2020","journal-title":"Cells"},{"key":"R36-20250918","first-page":"133","article-title":"Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.","volume":"43","author":"Song","year":"2020","journal-title":"Oncol Rep"},{"key":"R37-20250918","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1002\/jcb.28420","article-title":"Identifying novel biomarkers in hepatocellular carcinoma by weighted gene co-expression network analysis.","volume":"120","author":"Li","year":"2019","journal-title":"J Cell Biochem"},{"key":"R38-20250918","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/OTT.S188913","article-title":"Comprehensive analysis of potential prognostic genes for the construction of a competing endogenous RNA regulatory network in hepatocellular carcinoma.","volume":"12","author":"Yue","year":"2019","journal-title":"Onco Targets Ther"},{"key":"R39-20250918","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3892\/etm.2020.8843","article-title":"CacyBP\/SIP promotes tumor progression by regulating apoptosis and arresting the cell cycle in osteosarcoma.","volume":"20","author":"Zhao","year":"2020","journal-title":"Exp Ther Med"},{"key":"R40-20250918","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cbin.10889","article-title":"CacyBP\/SIP inhibits the migration and invasion behaviors of glioblastoma cells through activating Siah1 mediated ubiquitination and degradation of cytoplasmic p27.","volume":"42","author":"Yan","year":"2018","journal-title":"Cell Biol Int"},{"key":"R41-20250918","doi-asserted-by":"crossref","first-page":"1115272","DOI":"10.3389\/fimmu.2023.1115272","article-title":"By integrating single-cell RNA-seq and bulk RNA-seq in sphingolipid metabolism, CACYBP was identified as a potential therapeutic target in lung adenocarcinoma.","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"R42-20250918","doi-asserted-by":"crossref","first-page":"692941","DOI":"10.3389\/fmolb.2021.692941","article-title":"Downregulation of CacyBP by CRISPR\/dCas9-KRAB prevents bladder cancer progression.","volume":"8","author":"Zheng","year":"2021","journal-title":"Front Mol Biosci"},{"key":"R43-20250918","doi-asserted-by":"crossref","first-page":"12","DOI":"10.62347\/OWVW7440","article-title":"Pan-analysis reveals CACYBP to be a novel prognostic and predictive marker for multiple cancers.","volume":"16","author":"Mo","year":"2024","journal-title":"Am J Transl Res"},{"key":"R44-20250918","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bbamcr.2012.12.010","article-title":"CacyBP\/SIP as a novel modulator of the thin filament.","volume":"1833","author":"Jurewicz","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"R45-20250918","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.bbamcr.2010.07.003","article-title":"Tubulin binding protein, CacyBP\/SIP, induces actin polymerization and may link actin and tubulin cytoskeletons.","volume":"1803","author":"Schneider","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"R46-20250918","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00726-017-2404-7","article-title":"MAP kinase p38 is a novel target of CacyBP\/SIP phosphatase.","volume":"49","author":"Topolska-Wo\u015b","year":"2017","journal-title":"Amino Acids"},{"key":"R47-20250918","doi-asserted-by":"crossref","first-page":"9462","DOI":"10.1021\/bi0502689","article-title":"The modular structure of SIP facilitates its role in stabilizing multiprotein assemblies.","volume":"44","author":"Bhattacharya","year":"2005","journal-title":"Biochemistry"},{"key":"R48-20250918","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s13046-023-02885-w","article-title":"Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma.","volume":"42","author":"Wang","year":"2023","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T22:02:19Z","timestamp":1758232939000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":47,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043694","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}